Investor · 1 deal
Every published round Artesian Investments took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Nutromics | Unnamed stage | 9 Sep 2022 | $20.5m | Participant | Startup Daily (3 Sep 2025), SmartCompany, Startup Daily (9 Sep 2022), @AuManufacturing |
Companies Artesian Investments has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Nutromics | diagnostics startup | 9 Sep 2022 | 1 | 0 |
Fund closes reported for Artesian Investments, as distinct from the investments it has made.
Companies Artesian Investments has backed that another company then bought. An exit for the holding, not a deal Artesian Investments did.
Stories naming Artesian Investments. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
StrongRoomAI chief Max Mito denies EVP's fraud allegations in Federal Court; the startup is in administration ahead of a sale after the Sydney VC's $17m backing unravelled into litigation.
EVP alleges StrongRoom AI's CEO admitted fabricated revenue and debt figures after the Sydney VC invested $10.4m in a $17m raise; the Melbourne startup is now in administration with assets frozen.
Melbourne wearable diagnostics startup Nutromics raised US$14 million (A$20.5 million), led by Dexcom's venture arm with VU Venture Partners and Artesian, to fund clinical studies and expansion.